Complement forms a key arm of innate immune defenses against gonococcal infection. Sialylation of gonococcal lipo-oligosaccharide, or expression of porin 1A (Por1A) protein, enables Neisseria gonorrhoeae to bind the alternative pathway complement inhibitor, factor H (fH), and evade killing by human complement. Using recombinant fH fragment-murine Fc fusion proteins, we localized two N. gonorrhoeae Por1A-binding regions in fH: one in complement control protein domain 6, the other in complement control proteins 18–20. The latter is similar to that reported previously for sialylated Por1B gonococci. Upon incubation with human serum, Por1A and sialylated Por1B strains bound full-length human fH (HufH) and fH-related protein 1. In addition, Por1A strains bound fH-like protein 1 weakly. Only HufH, but not fH from other primates, bound directly to gonococci. Consistent with direct HufH binding, unsialylated Por1A gonococci resisted killing only by human complement, but not complement from other primates, rodents or lagomorphs; adding HufH to these heterologous sera restored serum resistance. Lipo-oligosaccharide sialylation of N. gonorrhoeae resulted in classical pathway regulation as evidenced by decreased C4 binding in human, chimpanzee, and rhesus serum but was accompanied by serum resistance only in human and chimpanzee serum. Direct-binding specificity of HufH only to gonococci that prevents serum killing is restricted to humans and may in part explain species-specific restriction of natural gonococcal infection. Our findings may help to improve animal models for gonorrhea while also having implications in the choice of complement sources to evaluate neisserial vaccine candidates.
A novel ferroceneylazobenzene self-assembled monolayer (SAM) has been constructed on an indium-tin oxide (ITO) electrode via the covalent attachment of 4-(4'-11-ferrocenyl-undecanoxyphenylazo)benzoic acid ( FcAzCOOH) onto a silanized ITO substrate surface and verified by reflectance infrared spectroscopy and water contact angle. Atomic force microscopy (AFM) and cyclic voltammogram (CV) indicated that the FcAzCOOH formed a uniform and reproducible SAM on the ITO electrode with a surface coverage of ca. 1.9 x 10 (-10) mol/cm (2) (87 A (2)/molecule). The reversible photoisomerization behavior of the SAM was characterized by UV-vis spectra. The azo pi-pi* transition band intensity of the SAM gradually decreased with UV (365 nm) irradiation and was almost recovered again when subsequent exposure to ambient room light (400-800 nm). The increased tilt angle of the molecules on the ITO substrate after UV irradiation further confirmed the trans-to- cis isomerization of azobenzene moieties. The CV of the trans- FcAzCOOH modified ITO electrode showed a pair of waves due to redox of the ferrocene groups in the potential range of 0 to +800 mV (vs SCE), and the peak separation of the redox wave became larger after UV irradiation and almost returned to its original value after subsequent exposure to the visible light. Rate-dependent CV curves indicated that the charge transfer rate between the ferrocene species in the SAM and the ITO electrode was slowed down after UV irradiation due to the smaller porosity of the monolayer film and the more compact barrier layer between the redox species and the ITO electrode. It is the first time to directly observe the influence of photoisomerization of the azobenzene moiety on the redox behavior of redox species in the ferroceneylazobenzene-functionalized SAM. The present results provide profound insight into the role of redox microenvironment on electron transfer kinetics and also provide a simple and facile approach to the preparation of photocontrollable electrodes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.